Healthcare
-
Skylight Health Executes Definitive Agreement to Acquire NeighborMD to Expand in Florida and Enters Medicare Advantage Global Risk
Skylight executes a definitive agreement for the largest acquisition to date and secured a US $20 million credit line facility…
Read More » -
Healthcare Triangle Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
HITRUST Risk-based, 2-year Certification validates Healthcare Triangle is committed to meeting key regulations and protecting sensitive information PLEASANTON, Calif., April…
Read More » -
These Eye Problems Could Be Symptoms Of COVID-19 Coronavirus
Looks like the eyes may have it. You know those round things that sit below your forehead and you use…
Read More » -
NanoKnife FDA Approval Is The Highlight Of An Otherwise Tepid AngioDynamics Quarter
Latham, New York: AngioDynamics, Inc. (NASDAQ:ANGO) is a number one supplier of modern, minimally invasive medical units utilized by skilled…
Read More » -
Lexicon’s Volatility Could Be Your Friend After The Zynquista Rejection
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is an organization identified for locating novel drug targets and drug candidates developed from state-of-the-art medicinal…
Read More » -
Women’s Health Player, Establishment Labs Witnesses Rising Implant Sales; Delivers Mixed Results
New York, NY: Establishment Labs Holdings Inc. (NASDAQ:ESTA), is a world medical know-how firm centered on ladies’s health, within the…
Read More » -
Amphastar Had A Good 2018 With Multiple ANDA Approvals
Rancho Cucamonga, CA: Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) is a specialty pharmaceutical firm that focuses totally on creating, manufacturing, advertising, and…
Read More » -
Aerie Pharmaceuticals Delivers Mixed Result; Focus On International Expansion
Durhan, NC: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a scientific stage pharmaceutical firm targeted on offering therapies for the therapy of eye-related…
Read More » -
Gossamer Bio Starts Off Well, Trades 12% Above IPO Price On Day One
San Diego, CA: Upcoming biopharmaceutical firm, Gossamer Bio (NASDAQ:GOSS) had its debut on the NASDAQ on Friday, February 8th, 2019…
Read More » -
The Cancer Research Collaboration Partners with Diabetes Prevention Program Provider Blue Mesa Health with California Residents in Mind Nasdaq:RDNT
NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) — The Cancer Research Collaboration (CRC), a non-profit group devoted to increasing the…
Read More »
